CerebrolysinHealing & Recovery
Porcine brain-derived peptide mixture studied in stroke, brain injury and dementia trials.
Overview
Cerebrolysin is not a single peptide but a mixture of low-molecular-weight peptides and amino acids derived from porcine (pig) brain, researched for recovery after ischemic stroke, traumatic brain injury and dementia. It is used clinically in over 50 countries but is not approved in the US, and it has a much larger human literature than most compounds sold as research peptides, including randomized trials and meta-analyses. Those results are mixed: a 2023 Cochrane review found it probably does not reduce deaths after acute ischemic stroke and flagged a possible increase in non-fatal serious adverse events. In the US it is not FDA-evaluated and is sold for research use only; nothing here is medical or dosing advice.
Evidence
Anecdotal reports community-reported
What people describe in forums, blogs and uncontrolled clinic write-ups — experiential and unverified, not clinical evidence and not medical advice.
- Clarity, focus and 'the cloud lifting'commonly reported
The typical positive report is a head that feels clearer and calmer, 'like an amazing night's sleep', with sharper word retrieval; some say the lift starts within about 15 minutes of an IM dose, others that it builds over the course. Several describe a reset that fades over 3–6 months to a baseline about 10% above the start, and one who ran 5 mL five days a week for a month felt 'almost too sharp' but got migraines.
- Recovery after drug damage, withdrawal and akathisiaa sizeable minority
The most striking accounts come from people with a deficit: years of painful medication-induced akathisia that eased from the start of a course; an engineer whose drinking and drug years had him doubting he could keep working, who ran 5 mL IM five days on, two off for four weeks, twice; and a user through three litres in a year who says it turned opiate withdrawal into 'a cold' but adds little without a deficit.
- Nothing felt, fatigue and brain fog on consecutive daysa sizeable minority
Null reports are common: 5, 10 and even 25 mL IM plus intranasal attempts with 'absolutely nothing', 10 mL a day for 10–15 days with at most a slight mood lift, and a five-week IM cycle with zero effects. Regular users warn that the slight relaxation turns into trouble getting up in the morning if taken daily, and that consecutive dosing brings brain fog and fatigue, so many run it every other day.
- Long self-logs: stimulant-like drive, heightened senses, fatigue at 10 mLoccasionally reported
The most detailed logs (a tracked three-week run of 10 mL every other day, then a year of use) report productivity, mental endurance, confidence and heightened sight, smell and hearing, with tracked evening tiredness falling from 7.3 to 5.0 and caffeine hitting harder. The logger later calls it stimulatory, finds 10 mL/day brings fatigue and brain fog, and recommends at most 5 mL on four-weeks-on / two-off cycles.
- Serious adverse reports and intranasal warningsoccasionally reported
One user attributes a year of painful autoimmune neuropathy and inflamed hand and foot ligaments to a single 5 mL IV infusion given by a doctor, and now tells everyone to stay away; replies note the dose was low, that IV may carry more immune risk than IM, and that the account cannot be verified. Longer-standing users recall people snorting it with bad outcomes and call intranasal the route never to try.
- Skepticism: manufacturer-funded evidence, undefined mixturecommonly reported
A recurring argument is that the stroke and dementia trials were run or supplied by the manufacturer and downgraded by independent reviewers for risk of bias, that the product is an undefined mixture nobody can third-party test, and that it has a 'cult-like' following. The usual reply: nearly all new-drug trials are manufacturer-funded, and it has been prescribed in dozens of countries for decades.
Sources
Starting references for the library summary. These are not dosing instructions or medical advice.
Prices
Compare Cerebrolysin prices across vendors.
Compare prices — from $32.40For research-use educational context only. Not medical advice and not a recommendation to use any compound. Consult a qualified healthcare professional before any health decision.